20
Centaur Pharmaceuticals Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DIAZEPAM USP, with a corresponding US DMF Number 21860.
Remarkably, this DMF maintains an Active status since its submission on July 24, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 08, 2021, and payment made on July 06, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II